Jan 132017
Talent4Boards - Great Talent builds Great Boards
– CANADA, Vancouver – InMed Pharmaceuticals, Inc. (CSE: IN / OTCQB: IMLFF), today announced that Martin Bott, VP of Corporate Finance and Investment Banking at Eli Lilly & Company, has been appointed to InMed Board of Directors effective immediately.… => Read more
InMed Pharmaceuticals appoints Martin Bott to its Board of Directors
From:: InMed Pharmaceuticals appoints Martin Bott to its Board of Directors
Sorry, the comment form is closed at this time.